A Passive Immunotherapy, PEHRG214 in Patients Infected with Human Immunodeficiency Virus: A Phase I Study

http://www.100md.com 《传染病学杂志》 2003年第3期

APassiveImmunotherapy,PEHRG214inPatientsInfectedwithHumanImmunodeficiencyVirus:APhaseIStudy,PEHRG214(HRG)isapolyclonalantibodypreparationproducedbyimmunizationofgoatswithpurifiedhumanimmunodeficiencyvirus(HIV)antigens.InthisphaseIstudy,HRGwasadministeredintrav

    百拇医药网 http://www.100md.com/html/DirDu/2005/05/06/58/23/54.htm

您现在查看是摘要页，全文长 24690 字符。